London, 24 November 2014 – The high unmet need for personalized drugs has propelled growth in the Global Lung Cancer Therapeutics Market, which is expected to post a CAGR of 3.80 percent from 2015-2019, says research firm TechNavio.
There is currently no cure for lung cancer. Hence, drugs that cause disease remission in patients are expected to significantly drive market growth.
About the Report
The latest report by TechNavio emphasizes the increased adoption of personalized medicine, which provides more specific and targeted therapy, varying from person to person. Personalized medicine is dependent on the genetic structure of the patient and can be developed accordingly.
Genentech, a subsidiary of F. Hoffmann-La Roche, obtained approval for Tarceva, which is the first FDA approved therapy for the treatment of non-small cell lung cancer in the US. It is approved for the indication of Epidermal Growth Factor Receptor (EGFR) mutation-positive metastatic non-small cell lung cancer.
“Research efforts and investment are expected to increase as organizations like the Lung Cancer Alliance in the US generate awareness of the disease,” says Faisal Ghaus, Vice President of TechNavio.
“These associations provide support to patients in terms of access to medicines and reimbursement for testing and diagnosis of the disease. Additionally, they provide funding for research related to lung cancer, which will ultimately help the Lung Cancer Therapeutics Market grow through the projected period. ”
Key Information Covered in the Report:
Market segmentation, size and forecast through 2019
Market Growth Drivers:
- High Unmet Need
- For a full detailed list, view our report.
Market Challenges:
- High Cost of Treatment
- For a full detailed list, view our report.
Market Trends:
- Personalized Medicine
- For a full detailed list, view our report.
Key Vendors:
- AstraZeneca plc
- Celgene Corp.
- Eli Lilly and Co.
Other Prominent Vendors:
- Agennix
- Amgen
- Boehringer Ingelheim
- Celldex
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
